A patient returns to a PCP for follow-up care related to a UTI.

The CDI specialist shouldreview CKD staging criteria with the providerbecause assigning CKD based on asingle eGFR valuecan be clinically unreliable and may lead to inaccurate documentation and coding. Outpatient CDI guidance emphasizes that documentation must reflect a condition that isclinically valid, supported by the record, and accurately described, especially for chronic diseases. CKD is generally established by evidence of decreased kidney function or kidney damage that ispersistent, not a one-time lab that could be affected by hydration status, acute illness, medications, or transient physiologic changes. While an eGFR of52falls within the numeric range commonly associated withstage 3a, the key CDI issue is thefoundation for diagnosing chronic disease, not simply whether the number is “reportable.” Option A inappropriately directs CDI to add diagnoses to claims; CDI supports providers and coding, but does not independently “add” conditions. Option C is incorrect because chronic conditions may be coded when addressed/impact care, not only when actively treated. Option D is unsupported because eGFR 52 does not suggest stage 4.